Search Results - "Aguilar Schall, Raul E."

Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients by Kim, W. Ray, Berg, Thomas, Asselah, Tarik, Flisiak, Robert, Fung, Scott, Gordon, Stuart C, Janssen, Harry L.A, Lampertico, Pietro, Lau, Daryl, Bornstein, Jeffrey D, Aguilar Schall, Raul E, Dinh, Phillip, Yee, Leland J, Martins, Eduardo B, Lim, Seng Gee, Loomba, Rohit, Petersen, Jörg, Buti, Maria, Marcellin, Patrick

“…Background & Aims While the gold standard in the assessment of liver fibrosis remains liver biopsy, non-invasive methods have been increasingly used for…”
Get full text

Impact of long‐term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B by Kim, W. Ray, Loomba, Rohit, Berg, Thomas, Aguilar Schall, Raul E., Yee, Leland J., Dinh, Phillip V., Flaherty, John F., Martins, Eduardo B., Therneau, Terry M., Jacobson, Ira, Fung, Scott, Gurel, Selim, Buti, Maria, Marcellin, Patrick

“…BACKGROUND Efficacy trials have shown that antiviral therapy improves the outcomes of patients with chronic hepatitis B virus (HBV) infection. However,…”
Get full text

1876-P: Impact of Diabetes on Liver Disease Progression in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis (NASH) by SANYAL, ARUN J., ABDELMALEK, MANAL F., CALDWELL, STEPHEN, SHIFFMAN, MITCHELL L., GHALIB, REEM, LAWITZ, ERIC, JIANG, DEYUAN, AGUILAR SCHALL, RAUL E., MCCOLGAN, BRYAN J., MYERS, ROB, DJEDJOS, STEPHEN, MUIR, ANDREW, RATZIU, VLAD, AFDHAL, NEZAM, GOODMAN, ZACHARY, BOSCH, JAIME, HARRISON, STEPHEN A.

“…Background: Diabetes is a risk factor for advanced fibrosis due to NASH, but the effect of diabetes on disease progression is not well-characterized. Here, we…”
Get full text